National Institute of Mental Health; Notice of Closed Meetings, 22089-22090 [2018-10079]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices
for public comment. The Office of the
Report on Carcinogens (ORoC), Division
of the National Toxicology Program
(DNTP), National Institute of
Environmental Health Sciences (NIEHS)
prepared the monograph.
DATES:
Document Availability: The draft
monograph should be available by May
11, 2018, at https://ntp.niehs.nih.gov/
go/845046.
Written Public Comments
Submission: Deadline is June 1, 2018.
ADDRESSES: Written public comments
should be submitted electronically at
https://ntp.niehs.nih.gov/go/845046.
FOR FURTHER INFORMATION CONTACT: NTP
Meetings Staff, 2635 Meridian Parkway,
Suite 200, Durham, NC, USA 27713.
Phone: (919) 293–1660, Fax: (919) 293–
1645, Email: NTP-Meetings@icf.com.
SUPPLEMENTARY INFORMATION:
Background: The RoC is a
congressionally mandated, sciencebased, public health report that
identifies agents, substances, mixtures,
or exposures (collectively called
‘‘substances’’) in our environment that
pose a cancer hazard for people in the
United States. NTP prepares the RoC on
behalf of the Secretary of Health and
Human Services.
NTP follows a four-part process using
established listing criteria to evaluate
substances for possible listing in the
RoC and prepare the report (https://
ntp.niehs.nih.gov/go/rocprocess). For
each substance selected for review, a
draft RoC monograph is prepared that
presents (1) information on human
exposure to the substance; (2) an
assessment of the evidence from cancer
studies in humans and experimental
animals, mechanisms of carcinogenicity,
and other data relevant for evaluating
the substance’s potential
carcinogenicity; and (3) NTP’s
preliminary RoC listing
recommendation. This information is
presented in the substance profile in the
Helicobacter pylori (H. pylori)
monograph. The monograph also
includes a summary of strategies to
prevent H. pylori-associated cancers.
H. pylori was selected for review
following solicitation of public
comment, review by the NTP Board of
Scientific Counselors on April 11, 2016,
and approval by the NTP Director
(https://ntp.niehs.nih.gov/go/9741).
Information on the NTP review of H.
pylori is available at https://
ntp.niehs.nih.gov/go/791433. H. pylori
is a gram-negative, multi-flagellated
bacterium that colonizes the luminal
mucosal surface of the body (corpus)
and lower portion (antrum) of the
stomach; if untreated, the infection
VerDate Sep<11>2014
19:21 May 10, 2018
Jkt 244001
usually lasts for the individual’s
lifetime. Chronic infection can cause
gastritis and peptic ulcers. The
bacterium is spread by person-to-person
contact, especially among family
members. Risk factors for H. pylori
infection include age, race or ethnicity
(minority), socioeconomic status (low
family income and lower education
level), and crowded housing.
Request for Comments: NTP invites
written public comments on the draft
monograph. The deadline for
submission of written comments is June
1, 2018. Written public comments
should be submitted electronically at
https://ntp.niehs.nih.gov/go/845046.
Any other correspondence should be
sent to NTP Meetings Staff by email:
NTP-Meetings@icf.com. Persons
submitting written comments should
include their name, affiliation (if
applicable), phone, email, and
sponsoring organization (if any) with
the document. Written comments
received in response to this notice will
be posted on the NTP website (https://
ntp.niehs.nih.gov/go/845046), with the
submitter identified by name, affiliation,
and/or sponsoring organization.
Following the public comment period,
the draft monograph will undergo
external peer review by letter.
Comments that address scientific or
technical issues will be shared with
external scientists for their
consideration during the peer review.
Guidelines for public comments are at
https://ntp.niehs.nih.gov/ntp/about_ntp/
guidelines_publiccomments_508.pdf.
Background Information on RoC: Each
edition of the RoC is cumulative and
consists of substances newly reviewed
in addition to those listed in previous
editions. The Secretary of Health and
Human Services approves new listings.
For each listed substance, the RoC
contains a substance profile, which
provides information on cancer studies
that support the listing—including those
in humans and animals and studies on
possible mechanisms of action,
informational about potential sources of
exposure to humans, and current
Federal regulations to limit exposures.
The 14th RoC, the latest edition, was
published on November 3, 2016
(available at https://ntp.niehs.nih.gov/go/
roc).
Dated: May 2, 2018.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2018–10075 Filed 5–10–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
22089
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative: Tools to Facilitate HighThroughput Microconnectivity Analysis.
Date: June 5, 2018.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Confirmatory Efficacy Clinical Trials of NonPharmacological Interventions for Mental
Disorders.
Date: June 7, 2018.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer Division of
Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Early
Phase Developmental Pharma/Device
Clinical Trials.
Date: June 12, 2018.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
E:\FR\FM\11MYN1.SGM
11MYN1
22090
Federal Register / Vol. 83, No. 92 / Friday, May 11, 2018 / Notices
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: David I. Sommers, Ph.D.,
Scientific Review Officer Division of
Extramural Activities, National Institute of
Mental Health National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9606,
Bethesda, MD 20892, 301–443–7861,
dsommers@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants; National Institutes of Health, HHS)
Dated: May 8, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10079 Filed 5–10–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of Mira Applications.
Date: June 26, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott Chevy Chase,
5520 Wisconsin Avenue, Chevy Chase, MD
20815.
Contact Person: Robert Horowits, Ph.D.,
Scientific Review Officer, National Institute
of General Medical Sciences, National
Institutes of Health, 45 Center Drive, Room
3An.18, Bethesda, MD 20892–6200, 301–
594–6904, horowitr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
VerDate Sep<11>2014
19:21 May 10, 2018
Jkt 244001
Dated: May 8, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10077 Filed 5–10–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; UH2/UH3
Review.
Date: June 7, 2018.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
application.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W110 Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Robert E. Bird, Ph.D.,
Scientific Review Officer, Research Program
Review Branch Division of Extramural
Activities National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W110,
Bethesda, MD 20892–9750, 240–276–6344,
birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Multi-Site
R01 Review.
Date: June 14, 2018.
Time: 11:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W110, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Robert E. Bird, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W110,
Bethesda, MD 20892–9750, 240–276–6344,
birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Biological
Comparisons in Patient-Derived Models of
Cancer (U01).
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
Date: July 2, 2018.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
5W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W120,
Bethesda, MD 20892–9750, 240–276–6457,
mh101v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 8, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10076 Filed 5–10–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group;
Skeletal Muscle and Exercise Physiology
Study Section.
Date: June 4–5, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Virginian Suites, 1500 Arlington
Boulevard, Arlington, VA 22209.
Contact Person: Richard Ingraham, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
E:\FR\FM\11MYN1.SGM
11MYN1
]]>Agencies
[Federal Register Volume 83, Number 92 (Friday, May 11, 2018)]
[Notices]
[Pages 22089-22090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10079]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; BRAIN Initiative: Tools to Facilitate High-
Throughput Microconnectivity Analysis.
Date: June 5, 2018.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: Vinod Charles, Ph.D., Scientific Review Officer
Division of Extramural Activities, National Institute of Mental
Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6151,
MSC 9606, Bethesda, MD 20892-9606, 301-443-1606,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Confirmatory Efficacy Clinical Trials of Non-
Pharmacological Interventions for Mental Disorders.
Date: June 7, 2018.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Marcy Ellen Burstein, Ph.D., Scientific Review
Officer Division of Extramural Activities, National Institute of
Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room
6143, MSC 9606, Bethesda, MD 20892-9606, 301-443-9699,
[email protected].
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Early Phase Developmental Pharma/Device Clinical
Trials.
Date: June 12, 2018.
Time: 11:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Neuroscience Center, 6001
Executive
[[Page 22090]]
Boulevard, Rockville, MD 20852 (Virtual Meeting).
Contact Person: David I. Sommers, Ph.D., Scientific Review
Officer Division of Extramural Activities, National Institute of
Mental Health National Institutes of Health, 6001 Executive Blvd.,
Room 6154, MSC 9606, Bethesda, MD 20892, 301-443-7861,
[email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants; National Institutes of Health, HHS)
Dated: May 8, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10079 Filed 5-10-18; 8:45 am]
BILLING CODE 4140-01-P
